SPY306.42+0.87 0.29%
DIA256.95+1.68 0.66%
IXIC9,521.74-30.31 -0.32%

Momenta Pharmaceuticals Q1 EPS $(0.340) Beats $(0.480) Estimate, Sales $8.700M Beat $4.330M Estimate

Momenta Pharmaceuticals (NASDAQ:MNTA) reported quarterly losses of $(0.340) per share which beat the analyst consensus estimate of $(0.480) by 29.17 percent. This is a 26.09 percent increase over losses of $(0.460) per

Benzinga · 05/07/2020 11:25

Momenta Pharmaceuticals (NASDAQ:MNTA) reported quarterly losses of $(0.340) per share which beat the analyst consensus estimate of $(0.480) by 29.17 percent. This is a 26.09 percent increase over losses of $(0.460) per share from the same period last year. The company reported quarterly sales of $8.700 million which beat the analyst consensus estimate of $4.330 million by 100.92 percent. This is a 111.52 percent increase over sales of $4.113 million the same period last year.